|
EP4282419A1
(en)
|
2012-12-20 |
2023-11-29 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
GB201415347D0
(en)
*
|
2014-08-29 |
2014-10-15 |
Ucl Business Plc |
Signalling system
|
|
PL3560953T3
(pl)
*
|
2014-12-24 |
2024-05-13 |
Autolus Limited |
Komórka
|
|
KR102763121B1
(ko)
|
2015-02-06 |
2025-02-04 |
내셔널 유니버시티 오브 싱가포르 |
치료적 면역 세포의 효능의 향상 방법
|
|
EP4406604A3
(en)
|
2015-03-05 |
2024-10-23 |
Fred Hutchinson Cancer Center |
Immunomodulatory fusion proteins and uses thereof
|
|
GB201503742D0
(en)
|
2015-03-05 |
2015-04-22 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
JP6961490B2
(ja)
|
2015-04-08 |
2021-11-05 |
ノバルティス アーゲー |
Ｃｄ２０療法、ｃｄ２２療法、およびｃｄ１９キメラ抗原受容体（ｃａｒ）発現細胞との併用療法
|
|
GB201507115D0
(en)
*
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic Acid Construct
|
|
GB201507119D0
(en)
*
|
2015-04-27 |
2015-06-10 |
Ucl Business Plc |
Nucleic Acid Construct
|
|
US11655452B2
(en)
|
2015-06-25 |
2023-05-23 |
Icell Gene Therapeutics Inc. |
Chimeric antigen receptors (CARs), compositions and methods of use thereof
|
|
US11173179B2
(en)
|
2015-06-25 |
2021-11-16 |
Icell Gene Therapeutics Llc |
Chimeric antigen receptor (CAR) targeting multiple antigens, compositions and methods of use thereof
|
|
EP3439675A4
(en)
|
2016-04-08 |
2019-12-18 |
Purdue Research Foundation |
METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY
|
|
GB201610512D0
(en)
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Chimeric antigen receptor
|
|
GB201610515D0
(en)
*
|
2016-06-16 |
2016-08-03 |
Autolus Ltd |
Cell
|
|
CN109562126A
(zh)
*
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
ES2981703T3
(es)
|
2016-09-02 |
2024-10-10 |
Lentigen Tech Inc |
Composiciones y métodos para tratar cáncer con DuoCars
|
|
BR112019006781A2
(pt)
|
2016-10-07 |
2019-07-30 |
Novartis Ag |
receptores de antígeno quiméricos para o tratamento de câncer
|
|
NZ752984A
(en)
|
2016-11-22 |
2026-03-27 |
Nat Univ Singapore |
Blockade of cd7 expression and chimeric antigen receptors for immunotherapy of t-cell malignancies
|
|
EP3548055A4
(en)
|
2016-12-02 |
2020-08-19 |
University of Southern California |
SYNTHETIC IMMUNE RECEPTORS AND THEIR PROCESSES FOR USE
|
|
US11427633B2
(en)
*
|
2016-12-13 |
2022-08-30 |
Crage Medical Co., Limited |
Anti-CD19 humanized antibody and immune effector cell targeting cd 19
|
|
EP3567049A4
(en)
*
|
2016-12-28 |
2020-08-26 |
Green Cross Lab Cell Corporation |
CHEMERICAL ANTIGENIC RECEPTOR AND NATURAL KILLER CELLS EXPRESSING THE SAME
|
|
EP3568466A4
(en)
|
2017-01-10 |
2020-07-15 |
The General Hospital Corporation |
TARGETED T CELLS WITH CYTOTOXICITY TO IMMUNOSUPPRESSIVE CELLS
|
|
US11649288B2
(en)
|
2017-02-07 |
2023-05-16 |
Seattle Children's Hospital |
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents
|
|
WO2018160622A1
(en)
|
2017-02-28 |
2018-09-07 |
Endocyte, Inc. |
Compositions and methods for car t cell therapy
|
|
CN119409836A
(zh)
|
2017-03-17 |
2025-02-11 |
弗雷德哈钦森癌症中心 |
免疫调节融合蛋白及其用途
|
|
US12378297B2
(en)
|
2017-04-14 |
2025-08-05 |
The General Hospital Corporation |
Chimeric antigen receptor T cells targeting the tumor microenvironment
|
|
US20200048618A1
(en)
*
|
2017-04-18 |
2020-02-13 |
Autolus Limited |
Cell
|
|
EP3612210A4
(en)
*
|
2017-04-19 |
2021-01-27 |
Board Of Regents, The University Of Texas System |
MANIPULATED ANTIGEN RECEPTORS EXPRESSING IMMUNE CELLS
|
|
CN110650975B
(zh)
*
|
2017-05-15 |
2024-04-05 |
美国卫生和人力服务部 |
双顺反子嵌合抗原受体及其用途
|
|
CA3287539A1
(en)
|
2017-06-21 |
2026-03-02 |
Icell Gene Therapeutics Llc |
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF
|
|
US20210130775A1
(en)
*
|
2017-08-02 |
2021-05-06 |
Autolus Limited |
Cells expressing a chimeric antigen receptor or engineered tcr and comprising a nucleotide sequence which is selectively expressed
|
|
US20190038733A1
(en)
|
2017-08-10 |
2019-02-07 |
National University Of Singapore |
T cell receptor-deficient chimeric antigen receptor t-cells and methods of use thereof
|
|
CN109385402A
(zh)
*
|
2017-08-11 |
2019-02-26 |
上海恒润达生生物科技有限公司 |
一种等比例混合两种靶点cart细胞的制备方法及应用
|
|
CN107446937B
(zh)
*
|
2017-09-05 |
2020-12-25 |
深圳华云生物技术有限公司 |
嵌合抗原受体及其表达基因、光控调节的嵌合抗原受体修饰的t细胞及其应用
|
|
KR20260026092A
(ko)
|
2017-09-19 |
2026-02-25 |
메사추세츠 인스티튜트 오브 테크놀로지 |
키메라 항원 수용체 t 세포 요법을 위한 조성물 및 그의 용도
|
|
US10543263B2
(en)
*
|
2017-10-16 |
2020-01-28 |
Lentigen Technology Inc. |
Compositions and methods for treating cancer with anti-CD22 immunotherapy
|
|
US11649294B2
(en)
|
2017-11-14 |
2023-05-16 |
GC Cell Corporation |
Anti-HER2 antibody or antigen-binding fragment thereof, and chimeric antigen receptor comprising same
|
|
CN109988242A
(zh)
*
|
2018-01-02 |
2019-07-09 |
武汉波睿达生物科技有限公司 |
联合嵌合抗原受体、表达载体、慢病毒及t细胞
|
|
CN108101994B
(zh)
*
|
2018-01-04 |
2020-09-15 |
广东万海细胞生物科技有限公司 |
抗cd19抗体及其应用
|
|
US11311576B2
(en)
|
2018-01-22 |
2022-04-26 |
Seattle Children's Hospital |
Methods of use for CAR T cells
|
|
US12312416B2
(en)
|
2018-02-06 |
2025-05-27 |
Seattle Children's Hospital |
Fluorescein-specific cars exhibiting optimal t cell function against FL-PLE labelled tumors
|
|
WO2019157533A1
(en)
*
|
2018-02-12 |
2019-08-15 |
The General Hospital Corporation |
Chimeric antigen receptors targeting the tumor microenvironment
|
|
CN110157738B
(zh)
*
|
2018-02-13 |
2023-06-27 |
亘喜生物科技（上海）有限公司 |
靶向cd19和cd22的工程化免疫细胞及其应用
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
AU2019225174B2
(en)
|
2018-02-23 |
2025-11-20 |
Endocyte, Inc. |
Sequencing method for CAR T cell therapy
|
|
GB201807870D0
(en)
|
2018-05-15 |
2018-06-27 |
Autolus Ltd |
A CD79-specific chimeric antigen receptor
|
|
WO2019220109A1
(en)
|
2018-05-15 |
2019-11-21 |
Autolus Limited |
Chimeric antigen receptor
|
|
EP3784776A4
(en)
|
2018-05-23 |
2022-01-26 |
National University of Singapore |
Blockade of cd2 surface expression and expression of chimeric antigen receptors for immunotherapy of t-cell malignancies
|
|
AU2019302603A1
(en)
*
|
2018-07-13 |
2021-01-14 |
Nanjing Legend Biotech Co., Ltd. |
Co-receptor systems for treating infectious diseases
|
|
IL281428B2
(en)
|
2018-09-27 |
2024-10-01 |
Autolus Ltd |
Chimeric antigen receptor
|
|
AU2019346335B2
(en)
|
2018-09-28 |
2024-07-25 |
Massachusetts Institute Of Technology |
Collagen-localized immunomodulatory molecules and methods thereof
|
|
GB201816522D0
(en)
|
2018-10-10 |
2018-11-28 |
Autolus Ltd |
Methods and reagents for analysing nucleic acids from single cells
|
|
GB201820547D0
(en)
*
|
2018-12-17 |
2019-01-30 |
Oxford Univ Innovation |
Modified antibodies
|
|
GB201903237D0
(en)
|
2019-03-08 |
2019-04-24 |
Autolus Ltd |
Method
|
|
US20220145325A1
(en)
*
|
2019-03-08 |
2022-05-12 |
Autolus Limited |
Compositions and methods comprising engineered chimeric antigen receptor and modulator of car
|
|
AU2020275049A1
(en)
*
|
2019-05-16 |
2022-01-06 |
Nanjing Legend Biotech Co., Ltd. |
Engineered immune cells comprsing a recognition molecule
|
|
EP3980453A4
(en)
*
|
2019-06-07 |
2023-07-05 |
The Trustees of the University of Pennsylvania |
Dual car expressing t cells individually linked to cd28 and 4-1bb
|
|
WO2020252455A1
(en)
|
2019-06-13 |
2020-12-17 |
The General Hospital Corporation |
Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
|
|
WO2020263399A1
(en)
|
2019-06-26 |
2020-12-30 |
Massachusetts Institute Of Technology |
Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof
|
|
GB201910185D0
(en)
|
2019-07-16 |
2019-08-28 |
Autolus Ltd |
Method
|
|
WO2021009510A1
(en)
|
2019-07-16 |
2021-01-21 |
Autolus Limited |
Method for preconditioning a subject who is about to receive a t-cell therapy
|
|
CA3147020A1
(en)
*
|
2019-08-07 |
2021-02-11 |
Joe G.N. Garcia |
Anti-nampt antibodies and uses thereof
|
|
CN112390891B
(zh)
*
|
2019-08-14 |
2022-06-03 |
苏州方德门达新药开发有限公司 |
嵌合抗原受体及其构建方法和应用
|
|
CN110903401A
(zh)
*
|
2019-11-20 |
2020-03-24 |
浙江大学 |
一种靶向cd19的二代嵌合抗原受体及其表达载体与应用
|
|
IL293215A
(en)
|
2019-11-26 |
2022-07-01 |
Novartis Ag |
Chimeric antigen receptors that bind bcma and cd19 and their uses
|
|
EP4065157A1
(en)
*
|
2019-11-26 |
2022-10-05 |
Novartis AG |
Cd19 and cd22 chimeric antigen receptors and uses thereof
|
|
CN115210252A
(zh)
|
2020-02-04 |
2022-10-18 |
西雅图儿童医院（Dba西雅图儿童研究所） |
抗二硝基苯酚的嵌合抗原受体
|
|
CN115397440A
(zh)
*
|
2020-02-04 |
2022-11-25 |
西雅图儿童医院（Dba西雅图儿童研究所） |
用半抗原标记细胞刺激嵌合抗原受体t细胞的方法和组合物
|
|
MX2022011289A
(es)
*
|
2020-03-11 |
2022-12-08 |
Fundacio Inst De Recerca Contra La Leucemia Josep Carreras |
Porcion de direccionamiento a cd22 para el tratamiento de leucemia linfoblastica aguda de celulas b (b-all).
|
|
US20210340524A1
(en)
|
2020-05-01 |
2021-11-04 |
Massachusetts Institute Of Technology |
Methods for identifying chimeric antigen receptor-targeting ligands and uses thereof
|
|
US12433954B2
(en)
|
2020-05-01 |
2025-10-07 |
Massachusetts Institute Of Technology |
Methods of activating anti-CD19 chimeric antigen receptor (CAR) T cells using amphiphilic ligand conjugates comprising CAR-targeting protein sequence motifs
|
|
GB202006820D0
(en)
*
|
2020-05-07 |
2020-06-24 |
Autolus Ltd |
Cell
|
|
KR20230025005A
(ko)
|
2020-06-17 |
2023-02-21 |
얀센 바이오테크 인코포레이티드 |
만능 줄기세포의 제조를 위한 재료 및 방법
|
|
JP7846667B2
(ja)
|
2020-07-16 |
2026-04-15 |
レジェンド バイオテック アイルランド リミテッド |
Ｃｄ２０結合分子及びその使用
|
|
CA3189601A1
(en)
|
2020-07-24 |
2022-01-27 |
The General Hospital Corporation |
Enhanced virus-like particles and methods of use thereof for delivery to cells
|
|
EP4203981A2
(en)
*
|
2020-08-25 |
2023-07-05 |
CytoImmune Therapeutics, Inc. |
Bispecific antibody car cell immunotherapy
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
CN112481284B
(zh)
*
|
2020-12-07 |
2023-07-25 |
深圳瑞吉生物科技有限公司 |
一种编码CAR基因的mRNA、组合mRNA、构建方法、CAR-T细胞和应用
|
|
AR124414A1
(es)
|
2020-12-18 |
2023-03-22 |
Century Therapeutics Inc |
Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
|
|
KR102393776B1
(ko)
|
2020-12-30 |
2022-05-04 |
(주)이노베이션바이오 |
Cd22에 특이적인 인간화 항체 및 이를 이용한 키메라 항원 수용체
|
|
AU2022227021A1
(en)
*
|
2021-02-26 |
2023-09-21 |
Kelonia Therapeutics, Inc. |
Lymphocyte targeted lentiviral vectors
|
|
US20230174651A1
(en)
|
2021-06-23 |
2023-06-08 |
Janssen Biotech, Inc. |
Materials and methods for hinge regions in functional exogenous receptors
|
|
WO2023016554A1
(zh)
*
|
2021-08-13 |
2023-02-16 |
上海医药集团股份有限公司 |
靶向cd22的抗原结合蛋白及其用途
|
|
KR102829757B1
(ko)
*
|
2021-11-17 |
2025-07-09 |
(주)이노베이션바이오 |
인간화된 cd22에 특이적인 항체 및 이를 이용한 키메라 항원 수용체
|
|
US20260097122A1
(en)
|
2022-05-11 |
2026-04-09 |
Autolus Limited |
Cd19/c22 car t-cell treatment of high risk or relapsed pediatric acute lymphoblastic leukemia
|
|
WO2024018426A1
(en)
|
2022-07-22 |
2024-01-25 |
Janssen Biotech, Inc. |
Enhanced transfer of genetic instructions to effector immune cells
|
|
WO2024137508A1
(en)
*
|
2022-12-19 |
2024-06-27 |
Development Center For Biotechnology |
Chimeric antigen receptors, nucleic acids encod ing the same, and uses thereof in treating cancers
|
|
KR20260013442A
(ko)
*
|
2023-03-17 |
2026-01-28 |
카티전 테라퓨틱스, 인코포레이티드 |
키메라 항원 수용체의 장기 발현을 위해 조정된 세포내 신호전달 및 공동자극 도메인
|
|
WO2024246526A1
(en)
|
2023-05-30 |
2024-12-05 |
Autolus Limited |
Cd19car t-cell treatment of relapsed/refractory b-cell acute lymphoblastic leukaemia
|
|
EP4719443A1
(en)
*
|
2023-06-02 |
2026-04-08 |
Northeastern University |
Targeted immune cell therapy utilizing trail and tnf mediated apoptosis
|
|
WO2025088308A1
(en)
|
2023-10-23 |
2025-05-01 |
Autolus Limited |
Products and methods for treating autoimmune diseases
|
|
GB202403564D0
(en)
|
2024-03-12 |
2024-04-24 |
Autolus Ltd |
Method
|
|
WO2025215360A1
(en)
|
2024-04-09 |
2025-10-16 |
Autolus Limited |
Method
|
|
WO2025231185A1
(en)
|
2024-05-01 |
2025-11-06 |
Legend Biotech Ireland Limited |
Viral glycoprotein variants and uses thereof
|
|
NL2037811B1
(en)
|
2024-05-29 |
2025-12-12 |
Univ Oslo |
Treatment for Cancer
|
|
NL2037929B1
(en)
|
2024-06-11 |
2026-01-12 |
Prinses Maxima Centrum Voor Kinderoncologie B V |
Brain Organoid
|